These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3283651)

  • 1. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing.
    Bernards A; Paskind M; Baltimore D
    Oncogene; 1988 Apr; 2(4):297-304. PubMed ID: 3283651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
    Dasgupta P; Reddy EP
    Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of the chicken c-myb exon 9A.
    Schuur ER; Dasgupta P; Reddy EP; Rabinovich JM; Baluda MA
    Oncogene; 1993 Jul; 8(7):1839-47. PubMed ID: 8510928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence analysis of human abl and bcr-abl cDNAs.
    Fainstein E; Einat M; Gokkel E; Marcelle C; Croce CM; Gale RP; Canaani E
    Oncogene; 1989 Dec; 4(12):1477-81. PubMed ID: 2687768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and sequencing of the human c-abl 3' untranslated region.
    Andrews DF; Tompkins CK; Hendrickson SL; Singer JW
    Oncogene; 1990 Mar; 5(3):441-4. PubMed ID: 2179820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
    Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
    Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene.
    Grillot DA; González-García M; Ekhterae D; Duan L; Inohara N; Ohta S; Seldin MF; Nuñez G
    J Immunol; 1997 May; 158(10):4750-7. PubMed ID: 9144489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of the human c-myb gene.
    Westin EH; Gorse KM; Clarke MF
    Oncogene; 1990 Aug; 5(8):1117-24. PubMed ID: 2202948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
    Rouer E; Benarous R
    Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin.
    Alexander WS; Dunn AR
    Oncogene; 1995 Feb; 10(4):795-803. PubMed ID: 7862460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential splicing of the mouse B-myb gene.
    Kamano H; Burk B; Noben-Trauth K; Klempnauer KH
    Oncogene; 1995 Dec; 11(12):2575-82. PubMed ID: 8545114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternatively spliced c-mil/raf mRNA is predominantly expressed in chicken muscular tissues and conserved among vertebrate species.
    Dozier C; Ansieau S; Ferreira E; Coll J; Stehelin D
    Oncogene; 1991 Aug; 6(8):1307-11. PubMed ID: 1886707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
    Shin S; Steffen DL
    Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the neuron-specific alternative splicing product of the c-src proto-oncogene.
    Raulf F; Robertson SM; Schartl M
    J Neurosci Res; 1989 Sep; 24(1):81-8. PubMed ID: 2478722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
    Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel first exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specific usage.
    Kimura R; Yoshii H; Nomura M; Kotomura N; Mukai T; Ishihara S; Ohba K; Yanase T; Gotoh O; Nawata H; Morohashi K
    Biochem Biophys Res Commun; 2000 Nov; 278(1):63-71. PubMed ID: 11071856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human protein tyrosine phosphatase 1C (PTPN6) gene structure: alternate promoter usage and exon skipping generate multiple transcripts.
    Banville D; Stocco R; Shen SH
    Genomics; 1995 May; 27(1):165-73. PubMed ID: 7665165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.